Singulex, Inc., a privately-held biotechnology company is engaged in the therapeutic discovery and development of human disease management through improved diagnostics. The company’s technology is used in manufacturing systems to meet the needs in biomarker discovery and validation. Singulex has developed protein assays that are 100–1,000 times more sensitive and use 20–100 fold less sample enabling a detailed industrial-scale analysis of precious clinical specimen repositories, cell culture preparations, and other biological specimens. It is headquartered in California, the United States.

The Singulex, Inc. - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.